HARMONY or discord in cardiovascular outcome trials of GLP-1 receptor agonists?

HARMONY or discord in cardiovascular outcome trials of GLP-1 receptor agonists?

ग्रंथसूची विवरण
मुख्य लेखकों:	Mafham, M, Preiss, D
स्वरूप:	Journal article
प्रकाशित:	Elsevier 2018

समान संसाधन

GLP-1 receptor agonists and cardiovascular outcome trials: An update
द्वारा: Eirini Andrikou, और अन्य
प्रकाशित: (2019-11-01)

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
द्वारा: Kristensen, SL, और अन्य
प्रकाशित: (2019)

An updated perspective and pooled analysis of cardiovascular outcome trials of GLP-1 receptor agonists and SGLT-2 inhibitors
द्वारा: Mustafa Kılıçkap, और अन्य
प्रकाशित: (2021-02-01)

Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide
द्वारा: Fatemeh Taktaz, और अन्य
प्रकाशित: (2024-07-01)

Risk of stroke and retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: An eight RCTs meta-analysis
द्वारा: Jinjing Wei, और अन्य
प्रकाशित: (2022-12-01)

GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes
द्वारा: María Isabel del Olmo-Garcia, और अन्य
प्रकाशित: (2018-01-01)

Adverse effects of GLP – 1 Receptor Agonists
द्वारा: Anna Kasprzak, और अन्य
प्रकाशित: (2025-02-01)

GLP-1 Receptor Agonists and Kidney Protection
द्वारा: Eulalia Valentina Greco, और अन्य
प्रकाशित: (2019-05-01)

Impact of GLP-1 Receptor Agonists on Psoriasis and Cardiovascular Comorbidities: A Narrative Review
द्वारा: Haran K, और अन्य
प्रकाशित: (2024-11-01)

Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
द्वारा: Qiyuan Keith Liu
प्रकाशित: (2024-07-01)

Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update
द्वारा: Collin Vandemark, और अन्य
प्रकाशित: (2023-02-01)

Emerging role of GLP-1 receptor agonists in the treatment of obesity
द्वारा: Lisa M Neff, और अन्य
प्रकाशित: (2010-07-01)

Role and development of GLP-1 receptor agonists in the management of diabetes
द्वारा: Chee&nbsp;W Chia, और अन्य
प्रकाशित: (2009-05-01)

GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms
द्वारा: Daiji Kawanami, और अन्य
प्रकाशित: (2020-06-01)

The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction
द्वारा: Rizvi AA, और अन्य
प्रकाशित: (2022-04-01)

Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?
द्वारा: Miodrag Janić, और अन्य
प्रकाशित: (2024-12-01)

GLP-1 Receptor Agonists’ Impact on Fertility - A Review
द्वारा: Joanna Wojda, और अन्य
प्रकाशित: (2025-02-01)

GLP-1 receptor agonists and myocardial metabolism in atrial fibrillation
द्वारा: Jiani Zhong, और अन्य
प्रकाशित: (2024-05-01)

GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes
द्वारा: Sydney S. Wilbon, और अन्य
प्रकाशित: (2023-12-01)

GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight
द्वारा: Giulia Monti, और अन्य
प्रकाशित: (2022-06-01)

Emerging role of GLP-1 receptor agonists in the treatment of obesity
द्वारा: Neff LM
प्रकाशित: (2010-07-01)

GLP-1 receptor agonist as a modulator of innate immunity
द्वारा: Jun Chen, और अन्य
प्रकाशित: (2022-12-01)

Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
द्वारा: Francis S. Willard, और अन्य
प्रकाशित: (2020-09-01)

Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study
द्वारा: Sara Piccini, और अन्य
प्रकाशित: (2023-03-01)

GLP-1 receptor agonists—another promising therapy for Alport syndrome?
द्वारा: Jan Boeckhaus, और अन्य
प्रकाशित: (2025-03-01)

Advances in GLP-1 receptor agonists for pain treatment and their future potential
द्वारा: Yongtao He, और अन्य
प्रकाशित: (2025-02-01)

The Use of GLP-1 Receptor Agonists in the Treatment of Obesity in Women with PCOS
द्वारा: Aleksandra Jaroń, और अन्य
प्रकाशित: (2024-08-01)

Advances in GLP-1 receptor agonists for the treatment of type 2 diabetes
द्वारा: Hong Shurui
प्रकाशित: (2023-01-01)

A potentially serious adverse effect of GLP-1 receptor agonists
द्वारा: Jinmiao Lu, और अन्य
प्रकाशित: (2023-05-01)

The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease
द्वारा: Haiyang Du, और अन्य
प्रकाशित: (2022-11-01)

GLP-1 Receptor Agonist and Non-Alcoholic Fatty Liver Disease
द्वारा: Jinmi Lee, और अन्य
प्रकाशित: (2012-08-01)

Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide
द्वारा: Karen Schneck, और अन्य
प्रकाशित: (2024-03-01)

The benefits of GLP1 receptors in cardiovascular diseases
द्वारा: Lamija Ferhatbegović, और अन्य
प्रकाशित: (2023-12-01)

GLP-1 agonists in treatment of obesity
द्वारा: Władysław Orłowski, और अन्य
प्रकाशित: (2023-01-01)

Comparative cardiovascular effects of GLP‐1 agonists using real‐world data
द्वारा: Amisha Wallia, और अन्य
प्रकाशित: (2023-05-01)

GLP-1 receptor agonists: a review of head-to-head clinical studies
द्वारा: Jennifer M. Trujillo, और अन्य
प्रकाशित: (2015-02-01)

Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice
द्वारा: Enrico Longato, और अन्य
प्रकाशित: (2020-06-01)

Healthcare professionals' perceptions and management of obesity & knowledge of glucagon, GLP‐1, GIP receptor agonists, and dual agonists
द्वारा: W. Timothy Garvey, और अन्य
प्रकाशित: (2024-06-01)

Methodological considerations in assessing GLP-1 receptor agonists and gastrointestinal cancer risk
द्वारा: Cheng-Hsien Hung, और अन्य
प्रकाशित: (2024-12-01)

Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events
द्वारा: Long He, और अन्य
प्रकाशित: (2024-07-01)